Stock MRMD MARIMED INC.
Add to a list
To use this feature you must be a member
Log inSign up

Ratings MariMed Inc.

Equities

MRMD

US56782V1070

Market Closed - OTC Markets
Other stock markets
 01:24:29 11/05/2024 am IST 		5-day change 1st Jan Change
0.2625 USD -4.58% Intraday chart for MariMed Inc. -12.50% -4.48%
09/05 Transcript : MariMed Inc., Q1 2024 Earnings Call, May 09, 2024
08/05 MariMed Inc. Provides Earning Guidance for the Full Year 2024 CI

Summary

  • On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.

Strengths

  • The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
  • The opinion of analysts covering the stock has improved over the past four months.
  • Consensus analysts have strongly revised their opinion of the company over the past 12 months.

Weaknesses

  • The company is in debt and has limited leeway for investment
  • For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
  • The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
  • The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
  • Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.

Ratings chart - Surperformance

Sector: Drug Retailers

1st Jan change Capi. Investor Rating ESG Refinitiv
MARIMED INC. Stock MariMed Inc.
-4.48% 99.66M -
GREEN THUMB INDUSTRIES INC. Stock Green Thumb Industries Inc.
+17.55% 3.03B
D+
VERANO HOLDINGS CORP. Stock Verano Holdings Corp.
+15.99% 1.72B -
TERRASCEND CORP. Stock TerrAscend Corp.
+3.18% 484M -
HIGH TIDE INC. Stock High Tide Inc.
+45.54% 180M -
CANTOURAGE GROUP SE Stock Cantourage Group SE
+2.37% 97.37M - -
GOLD FLORA CORPORATION Stock Gold Flora Corporation
+56.25% 71.9M -
C
NOVA CANNABIS INC. Stock Nova Cannabis Inc.
+44.94% 54.13M - -
Investor Rating
Trading Rating
-
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
-
EBITDA / Sales
Profitability
-
Finances

Valuation

P/E ratio
-
EV / Sales
Price to Book
-
Price to Free Cash Flow
-
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
-
4 months EPS revision
-

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
-
Earnings quality
  1. Stock Market
  2. Equities
  3. MRMD Stock
  4. Ratings MariMed Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW